Definitive Contract 75N91022C00024
Award Date 8/25/22
Potential Completion Date 12/14/23
Potential Value $400K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30308, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $4,100,000.00, was made by the National Institutes of Health (NIH) to Lymphatech, Inc., a small, minority-owned business located in Atlanta, Georgia. The contract is for the development of an "ALL-IN-ONE PRESSURE, FLOW CONTROL, AND IMAGING FOR CULTURING AND MONITORING LYMPHATIC MICROPHYSIOLOGIC SYSTEM" under the Small Business Innovation Research (SBIR) program. The original solicitation, SOLICITATION 75N91024R00006, was issued by the Advanced...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute, a civilian agency, to Lynntech Inc., a small business technology development company. The $299,984 firm-fixed-price contract is for research and development in the biomedical field, specifically basic research. The contract was set aside for small businesses. Lynntech has extensive experience conducting contracted research and prototype development for various government...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $2 million firm fixed price definitive contract to Carina Medical LLC as a total small business set aside. The contract is for Fiscal Year 2023 Small Business Innovation Research Topic 402 Phase II efforts to enhance the performance of artificial intelligence for lymph node detection, segmentation and measurements in multi-modality medical imaging, and to develop additional...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
- This $2,049,554 firm fixed price definitive contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sentimetrix, Inc., a for-profit small business. The contract supports the SBIR Phase II effort for "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)," which was previously funded under a $454,907 SBIR Phase I contract in 2021. The PATHML effort aims to develop machine learning techniques to analyze human posture...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a part of the Department of Health and Human Services, to Sonanutech Inc., a self-certified small disadvantaged business. The $299,364.00 fixed-price contract is for research and development in the medical and biomedical basic research domain. The contract has a performance period ending on December 31, 2017. No additional details about any larger contract vehicle or major...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (NIH NCI) awarded a Small Business Innovation Research (SBIR) Phase II contract to L2 Diagnostics LLC, a for-profit limited liability company, to develop predictive biomarkers for adverse reactions to prostate cancer radiotherapy. The $1,996,011.00 firm-fixed-price contract has a completion date of September 18, 2020 and is set aside for small businesses. L2 Diagnostics is a provider of goods...
- This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract was awarded to Veloxai LLC, a self-certified small disadvantaged business, to develop an automatic treatment planning system for high-dose rate brachytherapy for cervical cancer in low-resource settings. The contract was set aside for total small businesses and has a completion date of September 14,...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...